For years, Pfizer was the only drugmaker with treatments for the disease, called ATTR-CM, but BridgeBio’s CEO said in an ...

This coming Thursday was supposed to be the deadline for federal health systems to show the patient care decision-making ...

Here are eight possible indicators of how health secretary Robert F. Kennedy Jr. may handle U.S. vaccine policy in coming ...

Earlier this month, the FDA delayed a decision on whether to grant full approval to Novavax’s Covid-19 vaccine, and over the ...

Confusion over the FDA delay in granting full approval to Novavax’s Covid-19 vaccine deepened over the weekend, with possible ...

STAT senior writer Helen Branswell reflects on the trajectory of the Covid-19 pandemic: about the wishful thinking that led ...

In today's Morning Rounds newsletter, HHS axes an autism registry, the Trump presidency approaches 100 days, and funding for ...

Some key public health figures are taking an extraordinary step to try to shore up U.S. vaccination policy, feared to be ...